Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBrandon Kitay, MD, PhD
Assistant Professor Adjunct, PsychiatryAbout
Research
Publications
2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol
Wilkinson S, Prashad S, Dalthorp R, Harding L, Kitay B, Parikh S, Dziura J, Clayton A, Fram G, Lepoutre V, Brown J, Ostroff R, Sanacora G. Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol. Contemporary Clinical Trials 2026, 164: 108273. PMID: 41780747, DOI: 10.1016/j.cct.2026.108273.Peer-Reviewed Original ResearchQuick Inventory of Depressive SymptomatologyTreatment-resistant depressionIntranasal esketamineInventory of Depressive SymptomatologyIV ketamineS-enantiomer of ketamineRapid-acting antidepressantsIN esketamineAnxious distressAnxiety severityDepression severityDepressive symptomatologyPsychiatric illnessEsketamineComparative effectiveness studiesWeeks of treatmentDepressionNon-inferiorityRemission rateKetamineFDA-approved therapiesNon-inferiority studyPatient-reported outcomesAdjunctive therapyClinical differences
2025
97. GLOBAL VARIATIONS IN ELECTROCONVULSIVE THERAPY USAGE: A COMPARATIVE CASE SERIES ON SCHIZOPHRENIA IN THE UNITED STATES
Park S, Kim J, Touponse S, Mandell A, Hong J, Crowell A, Hermida A, Kitay B, McDonald W, Posse P, Hershenberg R. 97. GLOBAL VARIATIONS IN ELECTROCONVULSIVE THERAPY USAGE: A COMPARATIVE CASE SERIES ON SCHIZOPHRENIA IN THE UNITED STATES. American Journal Of Geriatric Psychiatry 2025, 33: s71-s72. DOI: 10.1016/j.jagp.2025.04.099.Peer-Reviewed Original ResearchClinical Global Impression-SeverityClinical Global Impression-ImprovementBeck Depression InventoryElectroconvulsive therapy treatmentsTreatment-resistant depressionPatient Health Questionnaire-9Schizoaffective disorderElectroconvulsive therapyGAD-7Major depressionMood stabilizersECT treatmentDiagnosis of obsessive-compulsive disorderRemission of psychotic symptomsCGI-I scoreTreatment of schizophreniaECT initiationGeneralized Anxiety Disorder 7-itemObsessive-compulsive disorderSevere psychiatric conditionsStabilization of moodEffect of ECT treatmentECT literatureAutism spectrum disorderDegree of paranoia114. FUNCTIONING AND DISABILITY IMPROVEMENT DURING AN ACUTE COURSE OF ECT IN GERIATRIC AND NON-GERIATRIC PATIENTS.
Mandell A, Kim J, Hong J, Park S, Touponse S, Crowell A, Hermida A, Kitay B, McDonald W, Posse P, Hershenberg R. 114. FUNCTIONING AND DISABILITY IMPROVEMENT DURING AN ACUTE COURSE OF ECT IN GERIATRIC AND NON-GERIATRIC PATIENTS. American Journal Of Geriatric Psychiatry 2025, 33: s83-s84. DOI: 10.1016/j.jagp.2025.04.116.Peer-Reviewed Original ResearchAcute course of ECTCourse of ECTTreatment-resistant depressed patientsElectroconvulsive therapyDepressed patientsAcute courseAcute seriesCharacteristics of depressionElectroconvulsive therapy researchSDS scoresGroup 2Group 1Depressive disorderHealth-related qualityBipolar disorderGeriatric populationCognitive functionClinical populationsNon-geriatric patientsDepressionNeuromodulation treatmentsNo significant differenceHealth-related quality of lifeSheehanElderly patientsA Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression
Laszcz J, Wang C, Riva-Posse P, Kim J, Tsygankova V, Mandell A, Rice H, Hermida A, Kitay B, Crowell A, McDonald W, Hershenberg R. A Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression. Journal Of Ect 2025, 41: 250-256. PMID: 39853314, DOI: 10.1097/yct.0000000000001113.Peer-Reviewed Original ResearchTreatment-resistant depressionTreatment-resistant depressed patientsElectroconvulsive therapySymptoms of depressionSymptoms of anxietyAnxiety symptomsDepressive symptomsAcute course of ECTGeneralized Anxiety Disorder 7 scalePredictors of antidepressant responseImprovement of anxiety symptomsImpact of electroconvulsive therapyCourse of ECTImprove symptoms of anxietyHigher symptoms of anxietyBeck Depression Inventory IIAnxiety symptom severityNaturalistic outpatient settingAcute ECT courseHigher levels of anxietyElectroconvulsive therapy treatmentsLevels of anxietyTrajectory of improvementAntidepressant responseAnxious symptoms
2024
P22: Comparative Analysis of Efficacy of Intravenous Ketamine and Intranasal Esketamine in Treatment-Resistant Depression across Age Groups
Hutchison C, Hermida A, Keshishyan A, Kitay B, Chatham A, Hershenberg R, Posse P, Posse P. P22: Comparative Analysis of Efficacy of Intravenous Ketamine and Intranasal Esketamine in Treatment-Resistant Depression across Age Groups. International Psychogeriatrics 2024, 36: 130-131. DOI: 10.1017/s1041610224002552.Peer-Reviewed Original ResearchBeck Depression InventoryIntravenous ketamineIntranasal esketamineTreatment-resistant depressionRetrospective chart reviewAge groupsResistant depressionClinical responseDepression InventorySymptomatic improvementTreatment resistanceChart reviewEsketamineAcute coursePatientsDepressionKetamineTRDAgeBeckIntranasalInfusionGroupInventoryLifetime history of childhood adversity and substance abuse in patients with treatment resistant depression
Giampetruzzi E, McDonald W, Rice H, Kitay B, Hermida A, Posse P, Hershenberg R. Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression. Personalized Medicine In Psychiatry 2024, 43: 100122. DOI: 10.1016/j.pmip.2024.100122.Peer-Reviewed Original ResearchTreatment-resistant depressionAdverse childhood experiencesHistory of substance abuseSubstance abuseDepressive disorderAssociated with treatment-resistant depressionTreatment-resistant depressed patientsPersistent depressive disorderLifetime substance abuseEffects of adverse childhood experiencesRisk of substance abuseAssociation of adverse childhood experiencesACE subtypesACE exposureResistant depressionLifetime historyChildhood adversityChildhood experiencesAbuseClinical samplesDepressionDisordersLogistic regression analysisMDDSubstancesChapter 19 Deep brain stimulation for depression
Kitay B, Riva-Posse P. Chapter 19 Deep brain stimulation for depression. 2024, 451-478. DOI: 10.1016/b978-0-443-18496-3.00019-7.Peer-Reviewed Original ResearchMajor depressive disorderTreatment-refractory depressionObsessive-compulsive disorderDeep brain stimulationBrain stimulationTarget of deep brain stimulationAntidepressant therapyDepressive disorderNeuropsychiatric disordersClinical psychiatryDepressionDisordersMovement disordersNetwork hypothesisPsychotherapyTherapeutic optionsSurgical interventionPsychiatryNeuromodulation technologyStimulationEpilepsyInterventionHypothesisTechnical advancesPharmacology
2023
P1: Dosing and treatment outcomes of rTMS for treatment-resistant depressed older adults in a naturalistic outpatient clinic population.
Tan A, Patricia A, Hershenberg R, Chatham A, Giampetruzzi E, Tsygankova V, Job G, Crowell A, Posse P, McDonald W, Kitay B. P1: Dosing and treatment outcomes of rTMS for treatment-resistant depressed older adults in a naturalistic outpatient clinic population. International Psychogeriatrics 2023, 35: 191-192. DOI: 10.1017/s1041610223003368.Peer-Reviewed Original ResearchRepetitive transcranial magnetic stimulationTreatment-resistant depressionWithin-group reductionsAnxiety scoresAnxiety symptom severityGroup 2Repetitive transcranial magnetic stimulation studiesGroup 1Depressed older adultsCognitive side effectsSelf-reported depressionEffects of repetitive transcranial magnetic stimulationReduction of depressionOlder adultsReduction of anxietyInternational meta-analysesAdult patientsRetrospective chart review of patientsChart review of patientsOutpatient sampleAnxiety symptomsResponse rateTranscranial magnetic stimulationDepressive symptomsNon-older patients
2019
The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion
Kitay BM, Katz RB, Wilkinson ST, Ostroff RB. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2019, 35: e4-e5. PMID: 29952859, PMCID: PMC6309946, DOI: 10.1097/yct.0000000000000516.Peer-Reviewed Original Research
2018
50 Studies Every Psychiatrist Should Know
Chapter 18: Memantine in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil. Brandon M. Kitay and Rajesh R. Tampi; Chapter 29: Exposure and Ritual Prevention, Clomipramine, or Their Combination for Obsessive-Compulsive Disorder. Brandon M. Kitay and Michael H. BlochBooks